Retatrutide – 15mg
-
In stock
Compound Overview
Retatrutide is a next-generation investigational peptide designed as a tri-agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. This triple mechanism offers a synergistic approach to metabolic research, blending the appetite-suppressing and insulin-modulating actions of incretin mimetics with the fat-burning, energy-expenditure-enhancing effects of glucagon receptor activation.
Unlike single or dual-agonist GLP-1 analogues, Retatrutide’s tri-receptor profile positions it as a novel tool for obesity, insulin resistance, and energy homeostasis modeling.
Research Context
Storage & Handling
Intended Use
Vendor: True Science Peptides
Product title: Retatrutide – 15mg